14. Tseng WF, Huang SS, Huang JS (2004) LRP-1/TbetaR-V mediates TGF- beta1-induced growth inhibition in CHO cells. FEBS Lett 562: 71–78. 15. Boucher P, Li WP, Matz RL, Takayama Y, Auwerx J, et al. (2007) LRP1 functions as an atheroprotective integrator of TGFbeta and PDFG signals in the vascular wall: implications for Marfan syndrome. PLoS ONE 2: e448. 16. Kundra V, Escobedo JA, Kazlauskas A, Kim HK, Rhee SG, et al. (1994) Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 367: 474–476. 17. DeMali KA, Whiteford CC, Ulug ET, Kazlauskas A (1997) Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cgamma or phosphatidylinositol 3 kinase. J Biol Chem 272: 9011–9018. 18. Heuchel R, Berg A, Tallquist M, Ahlen K, Reed RK, et al. (1999) Platelet- derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol–39 kinase signaling. Proc Natl Acad Sci U S A 96: 11410–11415. 19. Kounnas MZ, Morris RE, Thompson MR, FitzGerald DJ, Strickland DK, et al. (1992) The alpha 2-macroglobulin receptor/low density lipoprotein receptor- related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem 267: 12420–12423. 20. Willnow TE, Herz J (1994) Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J Cell Sci 107 (Pt 3): 719–726. 21. Robinson PN, Arteaga-Solis E, Baldock C, Collod-Beroud G, Booms P, et al. (2006) The molecular genetics of Marfan syndrome and related disorders. J Med Genet 43: 769–787. 22. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, et al. (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407–411. 23. Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, et al. (2004) TGF-beta- dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114: 1586–1592. 24. Singh KK, Rommel K, Mishra A, Karck M, Haverich A, et al. (2006) TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat 27: 770–777. 25. Akutsu K, Morisaki H, Takeshita S, Sakamoto S, Tamori Y, et al. (2007) Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta receptor genes. Circ J 71: 1305–1309. 26. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, et al. (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92: 883–893. LRP1 Controls Vascular PI3K 27. Arvidsson AK, Heldin CH, Claesson-Welsh L (1992) Transduction of circular membrane ruffling by the platelet-derived growth factor beta-receptor is dependent on its kinase insert. Cell Growth Differ 3: 881–887. 28. Wennstrom S, Hawkins P, Cooke F, Hara K, Yonezawa K, et al. (1994) Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol 4: 385–393. 29. Wennstrom S, Siegbahn A, Yokote K, Arvidsson AK, Heldin CH, et al. (1994) Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 39 kinase. Oncogene 9: 651–660. 30. Hooshmand-Rad R, Claesson-Welsh L, Wennstrom S, Yokote K, Siegbahn A, et al. (1997) Involvement of phosphatidylinositide 39-kinase and Rac in platelet- derived growth factor-induced actin reorganization and chemotaxis. Exp Cell Res 234: 434–441. 31. Tallquist MD, Klinghoffer RA, Heuchel R, Mueting-Nelsen PF, Corrin PD, et al. (2000) Retention of PDGFR-beta function in mice in the absence of phosphatidylinositol 39-kinase and phospholipase Cgamma signaling pathways. Genes Dev 14: 3179–3190. 32. Ramirez F, Dietz HC (2007) Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 17: 252–258. 33. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, et al. (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117–121. 34. Nataatmadja M, West J, West M (2006) Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 114: I371–377. 35. Sheehan DC, Hrapchak BB (1987) Theory and Practice of Histotechnology: Battelle. 36. Woods AE, Ellis RC (1995) Histopathology, A Complete Reference: Churchill Livingston. 37. Yu M, Gu SM, Zhou L, Zhao GF, Yu LQ, et al. (2003) [Molecular basis of preventive effect of human apolipoprotein-1 on murine vascular smooth muscle cell proliferation and lipid deposition induced by oxidized low density lipoprotein]. Zhonghua Yi Xue Za Zhi 83: 494–497. 38. Zhou L, Dong J, Yu M, Yin H, She M (2003) Age-dependent increase of NF- kappaB translocation and PDGF-B expression in aortic endothelial cells of hypercholesterolemic rats. Exp Gerontol 38: 1161–1168. 39. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Krebs EG, et al. (1994) Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 93: 1266–1274. PLoS ONE | www.plosone.org 11 September 2009 | Volume 4 | Issue 9 | e6922